Your session is about to expire
← Back to Search
Oxytocin Delivery Methods for C-Section (INBOX Trial)
INBOX Trial Summary
This trial found that giving oxytocin as a bolus (a one-time dose) is better than giving it as an infusion (a continuous drip) in terms of how quickly it works to improve uterine tone.
INBOX Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.INBOX Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Bolus arm
- Group 2: Infusion arm
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there vacancies for participants within this experiment?
"Affirmative. According to information available on clinicaltrials.gov, this medical investigation is currently recruiting participants since first being posted on March 15th 2022 and its last update taking place April 14th 2022. The trial aims to enroll 120 patients from a single centre."
Is there an opportunity to enroll in this clinical test?
"In order to take part in this research, applicants must have undergone a cesarean delivery and be between 18 and 45 years old. Presently, the study is seeking approximately 120 participants."
Is the minimum age requirement for this medical experiment 18 years or younger?
"Eligible candidates for this study must be over 18 and under 45 years of age."
How many participants are currently enrolled in this clinical trial?
"Affirmative. Clinicaltrials.gov data reveals this clinical trial, first posted on March 15th 2022, is actively seeking participants. It requires 120 individuals to be recruited at one medical centre for the study."
What potential health hazards might result from Bolus arm usage?
"A score of 3 was given to Bolus arm's safety as it is a Phase 4 trial and has thus received federal approval."
Share this study with friends
Copy Link
Messenger